Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755962 · ClinicalTrials.gov registry record · NA
Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity
A NA study of 160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All Ethnicity, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT01755962 is a NA study of 160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All Ethnicity that has completed, run by University of California, Los Angeles. The registered enrollment target is 88 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01755962, a NA study of 160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All Ethnicity, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is prompted by the urgent public health need to identify novel strategies to prevent cardiovascular disease (CVD) and type 2 diabetes (T2D). The higher prevalence of CVD, T2D, and metabolic syndrome in obese individuals is a major healthcare concern. Therefore, finding optimal intervention strategies to combat these growing epidemics is imperative.
Conditions Studied
Interventions
- OTHER Resistance Training
- OTHER Glycemic Load
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2012-04 |
| Est. Completion | 2017-12-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755962
The ClinicalTrials.gov registry entry for NCT01755962 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with 160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All Ethnicity appearing as the primary indexed condition, and to 2 interventions - of which Resistance Training is the first listed.
NCT01755962 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01755962 about?
NCT01755962 is a clinical study titled "Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity". This project is prompted by the urgent public health need to identify novel strategies to prevent cardiovascular disease (CVD) and type 2 diabetes (T2D). The higher prevalence of CVD, T2D, and metabolic syndrome in obese individuals is a major healthcare concern. Therefore, finding optimal intervent...
What is the current status of trial NCT01755962?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2012-04. Estimated completion is 2017-12-14.
What conditions does trial NCT01755962 study?
This clinical trial studies the following conditions: 160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All Ethnicity.
What interventions are being tested in trial NCT01755962?
The interventions under investigation include: Resistance Training (OTHER), Glycemic Load (OTHER).
Who is sponsoring clinical trial NCT01755962?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01755962 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.